Journal of Translational Medicine · 2023 · 38 citations · 29 references
Life SciencesBiostatisticsGeneticsEpidemiologyHuman GeneticsMedical GeneticsAmino Acid MetabolismCardiovascular DiseaseCardiovascular EpidemiologyGenetic RiskMendelian RandomizationAmino Acid Disease BiomarkersAmino AcidsAtherosclerosis GeneticsCardiovascular Disease IncidenceCardiovascular Disease MortalityCausal Relationships
BACKGROUND: Epidemiological studies demonstrated that multiple amino acids (AAs) were associated with cardiovascular diseases (CVDs), but whether these associations were causal remains unclear. This study aims to investigate the causal relationships between circulating levels of 20 AAs and 10 CVDs in European and East Asian populations by Mendelian randomization (MR). METHODS: This MR study utilized single-nucleotide polymorphisms that were significantly associated with AAs as instrumental variables. Summary-level data for AAs and CVDs were obtained from public genome-wide association studies. The causal effects were primarily estimated by inverse variance weighting with multiplicative random effect method. Sensitivity analyses, including weighted median, weighted mode, and MR Egger regression, were used to test the robustness of our results. RESULTS: In the European population, alanine and serine were inversely associated with angina pectoris (AP) and chronic heart failure, respectively. With each unit increase of leucine, the risk of ischemic stroke increased by 10%. Moreover, tyrosine was positively associated with AP and deep vein thrombosis. In the East Asian population, each unit increase in glycine was associated with 4.1% and 9.0% decreased risks of coronary artery disease (CAD) and myocardial infarction (MI), respectively. A unit increase in serine was associated with 13.1%, 12.6% and 15.5% decreased risks of AP, CAD and MI, respectively. Sensitivity analyses supported the robustness of our results. CONCLUSIONS: This MR study demonstrated significant causal effects of circulating levels of AAs on CVDs, indicating the potential use of AAs as biomarkers or as therapeutic targets for CVD in clinical scenarios.
29
Metabolite profiles and the risk of developing diabetes
Thomas J. Wang, Martin G. Larson, Ramachandran S. Vasan et al. · Nature Medicine · 2011 · 3.1K citations · Full text
A cross-population atlas of genetic associations for 220 human phenotypes
Saori Sakaue, Masahiro Kanai, Yosuke Tanigawa et al. · Nature Genetics · 2021 · 2.4K citations · Full text
An atlas of genetic influences on human blood metabolites
So–Youn Shin, Eric B. Fauman, Ann-Kristin Petersen et al. · Nature Genetics · 2014 · 1.6K citations · Full text
The MRC IEU OpenGWAS data infrastructure
Ben Elsworth, Matthew Lyon, Tessa Alexander et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 957 citations · Full text
Jack Bowden, Wes Spiller, Fabiola Del Greco M et al. · International Journal of Epidemiology · 2018 · 929 citations · Full text